登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C26H56N10 · 2HCl
化学文摘社编号:
分子量:
581.71
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
216-994-6
MDL number:
产品名称
阿来西定 二盐酸盐, ≥95% (HPLC)
Quality Level
assay
≥95% (HPLC)
form
powder
storage condition
desiccated
color
white to off-white
solubility
DMSO: ≥10 mg/mL
storage temp.
−20°C
SMILES string
Cl.Cl.CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC
InChI
1S/C26H56N10.2ClH/c1-5-9-15-21(7-3)19-33-25(29)35-23(27)31-17-13-11-12-14-18-32-24(28)36-26(30)34-20-22(8-4)16-10-6-2;;/h21-22H,5-20H2,1-4H3,(H5,27,29,31,33,35)(H5,28,30,32,34,36);2*1H
InChI key
BRJJFBHTDVWTCJ-UHFFFAOYSA-N
Application
己联双辛胍二盐酸盐已:
- 用作一种防腐剂,研究其在唾液微生物膜中的抗菌活性
- 用作一种定位于线粒体1 (PTPMT1)特异性抑制剂的蛋白酪氨酸磷酸酶,以研究其对CD8+ T细胞剩余呼吸能力和活力的影响
- 用作PTPMT1抑制剂,研究其在人巨细胞病毒(HCMV)感染的人包皮成纤维细胞(HFF)中复制的抗病毒作用
Biochem/physiol Actions
己联双辛胍二盐酸盐是一种双胍化合物。它已经被用于头颈癌的治疗。己联双辛胍二盐酸盐对几种真菌也表现出抗菌膜和抗真菌活性。由于其抗癌活性,可引起哺乳动物细胞线粒体凋亡。己联双辛胍二盐酸盐是口腔消毒剂和隐形眼镜溶液的组分。
己联双辛胍二盐酸盐是一种有效的选择性PTPMT1(线粒体蛋白酪氨酸磷酸酶1)抑制剂。己联双辛胍能够增加离体大鼠胰岛的胰岛素分泌。
Features and Benefits
《受体分类和信号转导》手册的 磷蛋白磷酸酶(酪氨酸) 页面有该化合物的介绍。想要浏览手册的其他页面, 请单击此处。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Protein tyrosine phosphatases' catalytic mechanism involves transient phosphorylation.
J A Chawner et al.
The Journal of applied bacteriology, 66(3), 253-258 (1989-03-01)
Strains of Providencia stuartii with demonstrated resistance towards chlorhexidine did not show such resistance towards either of the related biguanide antiseptics, alexidine or vantocil. Alexidine promoted a significantly faster alteration in the permeability of Escherichia coli cell membranes towards various
Hyun-Shik Kim et al.
International journal of oral science, 5(1), 26-31 (2013-03-16)
A previous study demonstrated that alexidine has greater affinity for the major virulence factors of bacteria than chlorhexidine. The aim of this study was to compare the antimicrobial activity of 1% alexidine with that of 2% chlorhexidine using Enterococcus faecalis-infected
Kenneth W Yip et al.
Molecular cancer therapeutics, 5(9), 2234-2240 (2006-09-21)
Despite advances in surgery, radiation, and chemotherapy, novel therapeutics are needed for head and neck cancer treatment. The objective of this current study was to evaluate alexidine dihydrochloride as a novel compound lead for head and neck cancers. Using a
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| A8986-10MG | 04061833217474 |
| A8986-50MG | 04061833401088 |
